A stem cell therapy trial aimed at reducing neuroinflammation in patients with presymptomatic Alzheimer’s disease is underway at UTHealth Houston.
Shareholders approve all proposals – Biotech Investments
Galenica AG / Key word(s): AGMEGM 7th Annual General Meeting: Shareholders approve all proposals 10.04.2024 / 17:29 CET/CEST Press release The seventh Annual General Meeting